Henrik Stage, ADCendo CEO
The biotech craze hits the Nordics, driving a record-high $62M Series A for a Copenhagen-based ADC player
With the biotech boom in the US in full swing, more money than ever is flowing into the industry — but that gusher hasn’t fully translated …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
